Year: 2008
Type: article
Abstract: While a coherent picture has begun to emerge about the biological and molecular mechanisms that create primary tumors, the processes that lead subsequently to invasion and metastasis have, until recently, been relatively obscure. However, over the past 5 years, research of diverse sorts has begun to generate the conceptual outlines that explain how high-grade malignancies arise. These discussions invariably are motivated by a widely accepted depiction of how metastatic dissemination occurs—the sequence termed the ‘invasion–metastasis cascade’ ( 1 ). Thus, primary tumor cells invade locally, enter into the circulation (intravasation), are transported through the circulation, are lodged in microvessels in distant tissues, invade the parenchyma of such tissue (extravasation) and form micrometastatic deposits, some of which eventually grow into macroscopic metastases, the last process being termed colonization. A major issue concerns the timing of acquisition of the ability to invade and metastasize. Is this ability a function of the great majority of cells within a primary tumor, or does it reflect the biology of a small subpopulation of cells in this tumor that have acquired the ability to invade and metastasize? If the great majority of cells in a primary tumor have a comparable if not identical ability to invade and metastasize, this suggests that such acquisition occurs early. Conversely, if these powers are an attribute of a relatively small subpopulation, this trait must be acquired relatively late during the course of primary tumor formation. This issue might be addressed by arguing from first principles. For example, if a subpopulation of cells that are especially favored to metastasize exists within a primary tumor, the clonal expansion of these cells would seem to have been favored during the successive mutation and selection cycles generating the clonal successions that drive multistep tumor pathogenesis forward. This model, however, confronts a conceptual difficulty: why should the phenotype of metastasis be selectively advantageous within the confines of a primary tumor? If it is not, this suggests that, to the extent that metastasis occurs, it does not represent a phenotype that has been actively selected during primary tumor formation ( 2 ). Accordingly, this phenotype may be an inadvertent consequence of the acquisition of alleles that did indeed confer growth advantage within the evolving primary tumor mass, that is, these alleles may act pleiotropically, encoding both selected phenotypes (growth and survival in the primary tumor) and unselected phenotypes (invasiveness and metastatic powers). Still, these arguments from first principles must give ground to empirical observations, since only the latter can definitively settle the early versus late debate. Here, one confronts the complexity of the invasion–metastasis cascade, which rivals that of the prior steps that led initially to the formation of a primary tumor. Accordingly, one can pose the question of whether the acquisition of metastatic traits requires the accumulation of a significant number of mutations that rival in number and variety the genetic lesions that lead initially to primary tumor formation. In fact, as evidence accumulates, it becomes increasingly plausible that metastatic dissemination does not depend on the acquisition of additional genetic lesions beyond those that are present in many primary tumors. (These discussions must focus on the mutant alleles that serve as ‘drivers’, i.e. those that were selected because they conferred advantageous biological phenotypes, rather than the ‘passenger’ mutations, which reflect the general increased mutability of tumor cell genomes and thereby constitute random genetic background noise.) ( 3 ) The evidence arguing against a necessary role of metastasis- specific mutations (acquired late) comes from at least three distinct sources. First, as has been documented on several occasions, one can, with some measure of success, determine the prognosis of primary tumors, especially their tendency to progress toward metastatic relapse, by examining the gene expression profile of these tumors. These gene expression profiles must reflect the differentiation program of the normal cell of origin as perturbed by the subsequently acquired somatic mutations (as well as promoter methylation events). For example, by using gene expression arrays to examine the transcription patterns of a large number of primary breast carcinomas, investigators have been able to predict, with some accuracy, which tumors are likely and which are unlikely to progress to metastatic relapse ( 4 , 5 ). This holds important implications for the mechanisms that govern metastasis, since they suggest that many cells, probably the great majority of neoplastic cells within a primary tumor, express a spectrum of genes that influence metastatic behavior. Conversely, this expression pattern cannot be that of a small minority subpopulation within the primary tumor, whose gene expression pattern would be fully obscured by the RNAs expressed by the majority cell population. Hence, it seems probably that eventual metastatic spread is determined relatively early in tumor progression, that is, early enough to be implanted in the great majority of the cells within a primary tumor ( 2 ). This in turn suggests that the genetic determinants that were selected during the initial multistep formation of the tumor also happen to be those that favor metastatic spread. A second indication of the determinants of eventual metastatic spread comes from research in my own laboratory, in which a variety of normal human cell types have been transformed to a tumorigenic state through the introduction of a defined set of genes, specifically those encoded by the SV40 virus early region (which specifies the large T and small t oncoproteins), the hTERT gene (which encodes the catalytic subunit of the telomerase holoenzyme), and a ras oncogene. When early passage human mammary epithelial cells were propagated in two alternative culture media, they yielded populations that exhibited distinct gene expression patterns and, upon transformation by these introduced genes, yielded tumorigenic cells that grew into two histopathologically distinct tumors—one a squamous cell carcinoma and the other an invasive ductal adenocarcinoma of the breast ( 6 ). These outcomes conform with a widely held preconception—that the differentiation program of the normal cell of origin is a strong determinant of the eventual behavior of tumor cells arising following transformation. Indeed, in this case, the expression patterns of the two transformed cell types closely resembled that of their respective normal precursors and showed relatively minimal resemblance to one another. More important for the present discussion, however, is the fact that one type of tumor—the invasive ductal carcinoma—metastasized to the lungs, whereas the other—the squamous cell carcinoma—did not ( 6 ). Since the two types of tumors had acquired the identical set of experimentally introduced genes, which formally mimic somatic mutations, this demonstrated that the differentiation program of the normal cell of origin represented a strong determinant of eventual metastatic spread. Hence, the nature of the normal cell of origin, which serves as the progenitor of all the neoplastic cells within a tumor, sets the stage for whether its descendants, years or decades later, will or will not show metastatic tendencies. An even more dramatic outcome was seen when normal human melanocytes were transformed with the same set of oncogenes. The resulting transformants, which represent a model of spontaneous melanomas, generated primary tumors from which hundreds of metastases arose in various organ sites throughout the body, vastly overshadowing the metastases that were formed by the above-described mammary adenocarcinomas ( 7 ). Here, one has an even more dramatic example of the fact that the differentiation program of the normal cell of origin exerts strong influence on whether or not metastasis will eventually occur. A third indication of the lack of metastasis-specific genes comes from a variety of studies of the genomes of primary tumor cells with those of their derived metastases, including extensive sequencing of their respective genomes. It is generally the case that the same set of genetic lesions that are present in the genomes of primary tumor cells are found as well in the genomes of their derived metastases ( 8 ). Once again, there is every reason to believe that the driving force for metastasis has not been specific genetic lesions that were acquired late during the multistep formation of a primary tumor. Together, these diverse lines of evidence suggest, but hardly rigorously prove, that the dissemination of cancer cells from a primary tumor occurs as an almost inadvertent side-effect of primary tumor formation rather than a trait that is actively selected during this multistep process. The description of how metastases arise must also address the complexities of the invasion–metastasis cascade, as laid out above. If there are not a large suite of additional mutations required to drive invasion and metastasis beyond those needed for primary tumor formation, how then do carcinoma cells—the topic of most of the discussion that follows—acquire the ability to complete all these steps? The answer here seems increasingly to depend, as it does in many other types of tumor-generating processes, on the fact that cancer cells appropriate complex biological programs that play roles in normal cell and organismic physiology. In the present case, the specific normal biological process involves the epithelial–mesenchymal transition (EMT), which plays key roles in many steps of normal morphogenesis ( 9 ). In particular, a number of distinct morphogenetic steps involve the local movement of epithelial cells or their translocation to distant sites in the developing embryo. In general, true epithelial cells are incapable of such movements; they may move laterally in the plane of the epithelium while retaining adhesion to the underlying basement membrane/basal lamina. However, active movement in other directions appears to be forbidden to them. Such departures from the plane of an epithelium depend on the shedding by epithelial cells of some of their native characteristics and the acquisition, instead, of mesenchymal cell traits; the latter cells are indeed capable of locomotion and invading the extracellular matrix that may impede their forward motion. In fact, EMTs play central roles in a number of distinct steps of embryogenesis, including gastrulation and the emigration of cells from the primitive neural crest to various destinations throughout the embryo ( 10 ). As has been demonstrated in recent years, EMTs can be programmed by a variety of transcription factors (TFs) that are activated transiently in various stages of embryogenesis and in specific locations within an embryo ( 11–16 ). The transient expression of such TFs during embryogenesis indicates that, by necessity, the shutdown of their expression may lead to the loss of their EMT-inducing effects and thus a reversing of the EMT. Therefore, once a cell has passed through an EMT induced by such a TF, in the subsequent absence of this TF, the cell may revert, via a mesenchymal–epithelial transition, to the epithelial state in which its ancestors existed. This suggests a still unproven notion: that the epithelial state represents the ‘ground state’, and that cells that have been induced to enter into a mesenchymal state will revert to the epithelial state unless their mesenchymal phenotype is actively supported. The fact that EMTs occur only in specific locations within an embryo suggests another important conclusion: they normally occur in cells in response to specific contextual signals that they receive from their surroundings, specifically the cells around them that create the local microenvironment. This suggests, by extension, that expression of EMT-inducing TFs may be determined in a neoplastic cell by the contextual signals that this cell receives from its neighbors. These depictions, on their own, do not indicate the relevance of the EMT to cancer pathogenesis. However, two key aspects of carcinoma cells point to the relevance of these embryonic programs and TFs to tumor progression. First, many of the phenotypes of embryonic cells are recapitulated by aggressive carcinoma cells. Second, many of the embryonic TFs that are known to play critical roles in orchestrating EMTs during embryogenesis are also found to be expressed in a variety of human tumor cells; indeed, their expression is often correlated with aggressive tumor cell-associated traits. These TFs include Slug, Snail, Twist, Goosecoid, SIP-1, FOXC2 and ZEB1. Most of these TFs were discovered through the study of developmental genetics, often in organisms far removed from mammals, including Xenopus and Drosophila . Their presence, often in highly conserved form, in the genomes of distantly related animals testifies to their initial development early in metazoan evolution and their critical roles in the embryogenesis of these diverse organisms. Taken together, these various lines of evidence suggest that the various TFs are appropriated in order to enable carcinoma cells to acquire the traits of high-grade malignancy. Included among these is an ability to invade, to resist apoptosis and to secrete the proteases that are required to break down extracellular matrix. In truth, the EMT and the expression of most of these TFs are not limited to early embryonic development: during wound healing in the adult, various types of EMT are activated transiently in order to enable this process to reach completion ( 17 ). As indicated above, during embryogenesis the expression of various EMT-inducing TFs appears to occur in response to certain contextual signals that are released by nearby cells. It seems likely that the same type of heterotypic signals impinge on various carcinoma cells during the process of carcinoma progression. Included among these are Wnts, Hedgehogs, members of the transforming growth factor-beta family, as well as ligands of It also seems likely that, in general, one of these ligands is on its own, of an instead, in many they seem to act to the EMT in cells. The that these are still In the of carcinoma it is likely that these heterotypic signals are released by mesenchymal cells that form the Such mesenchymal cells have a origin than the carcinoma cells that have mesenchymal via passage through an EMT. These cells are from the of the tissue in which the tumor from the which appears to generate a number of distinct types of mesenchymal progenitor cells that are released into the circulation and for local by carcinoma cells ( ). Such cells to enter into the and into a variety of mesenchymal cell including and cells. In fact, the of most is from a variety of mesenchymal cell types whose are still While still by observations, there is evidence to indicate that the EMT-inducing heterotypic signals are not released by the of early stage tumors. as tumor the becomes increasingly and indeed on the of that are in the of active wound healing or are It is these that are the likely of the heterotypic signals that EMTs in nearby carcinoma cells. This depiction of the activated and its role in an EMT within primary tumor cells holds an important for the behavior of carcinoma cells once they have a primary while the within the primary tumor may have induced them to an the that these cancer cells in distant sites of dissemination are likely to be In these the have not been perturbed by by cells and will not have these activated such are unlikely to EMT-inducing heterotypic In the absence of these it seems likely that the carcinoma cells will expression of EMT-inducing TFs and revert, via a transition, to the epithelial phenotype of their ancestors in the primary tumor. The absence of mesenchymal phenotypes in metastases has been by some as a of the that cancer cells must through an EMT in order to However, the known of the EMT such arguments The fact that heterotypic signals may an EMT in carcinoma cells another important of these cells do not to additional genetic in order to acquire the phenotypes with high-grade malignancy. when with an appropriate of contextual primary carcinoma cells will such phenotypes additional This another factors determine whether or not the cancer cells within a primary tumor will or will not an As above, the appropriate of heterotypic signals appears to be to this in the carcinoma cells must be to these It seems highly likely that the differentiation program of the normal cell of origin represents one critical determinant of this the that this differentiation program can set the stage for eventual years or decades tumor has been In the suite of somatic that are during primary tumor progression, including mutations and promoter methylation are also likely to play a key role in such However, at are still far from being able to how the of initial differentiation programs and subsequent somatic determine to EMT-inducing heterotypic The critical role of to signals also holds another for the evolution of if these traits are only in response to heterotypic signals from an activated then the traits cannot have been the of selection during the multistep evolution that led to the formation of a primary tumor. it is the generated alleles that confer to these rather than alleles that are selected during primary tumor formation traits that are selected during primary tumor formation. This to the of above, that the expression of highly traits occurs as an inadvertent consequence of the of alleles that were initially selected because they confer traits that on their own, to the phenotypes of invasion and The fact that carcinoma cells that an EMT mesenchymal phenotypes and invade into the tumor and then into normal an since these invading neoplastic cells at least from the true mesenchymal cells that them in the tumor and, on during the course of in the of normal the initial of tumors. This has some to the EMT as a It seems however, that this will be or later, because of two First, it is probably the case that most carcinoma cells an EMT do i.e. by down epithelial as and while mesenchymal as and Accordingly, at cells both epithelial and mesenchymal are likely to the invading neoplastic cells among the true mesenchymal cells in the A second fact is likely to cancer cells that have an carcinoma cells that have passed through an EMT express certain that are not to be expressed by true mesenchymal cells ( ). These two factors should the in invasive carcinoma cells present in small and large in the of carcinoma key question how the of EMT-inducing TFs cells to complete the various successive steps of the invasion–metastasis the distinct cell biological traits that these TFs can how are they in cancer cells to complete these complex steps? the traits once again, these TFs confer increased to cell of and it is plausible that the expression of one of these TFs should enable a primary tumor cell to invade locally, in the circulation, and for a limited of in the parenchyma of a tissue in which it has The subsequent of such a cell is Thus, a breast cancer cell in the the or the must an of extracellular matrix and cell types to which it is, at least This lack of cancer cells and their is likely to explain the of the last of the invasion–metastasis growth of a into a macroscopic metastasis that is, as termed colonization. It is that only a small number of out of the that are initially in into a macroscopic It also seems that is not a that is addressed by the traits programmed by an EMT-inducing be the increased to apoptosis with an EMT program should the survival of the cells within a This acquired trait does not, however, with the fact that these cells are to the of the tissue in which they have Still, if this is eventually by this would indicate that the expression of one of these TFs may almost all the steps of the invasion–metastasis the one of colonization. the one this would represent an conceptual of this since it would these complex steps in of the of or small of the it would how these TFs are and the of them in tissues, they on normal tissue While epithelial cancer cells have been here as highly in that they can enter into a mesenchymal this may not be in some human tumors, in which cancer cells seem to be in a mesenchymal Such EMT in be by of a number of at the genetic and biological However, only one has into in recent the which is in the epithelial cells that are termed its role in epithelial cell been as one of the epithelial the promoter of its encoding gene sites for a number of EMT-inducing TFs that serve to transcription ( ). The of expression seems to be one of the key of of these the same they through still this shutdown is with an of the various mesenchymal This expression as the of by EMT-inducing However, in certain tumors, expression is by in the gene including point mutations and that the of or fully the these carcinoma cells of the of this critical but in they another in the of these cells. In the absence of the that serve to it to the are of this may one of especially if it by and subsequent in This state may for example, in cells that have and since the latter to The resulting may then to the it can with the of with other to expression of a variety of genes, many of them in an including ( ). Hence, and loss of in of resulting in a that may to the mesenchymal state following of an EMT. of the of the EMT may serve to explain how carcinoma cells are able to the primary tumor and at distant It is at present whether aggressive tumors arising from embryonic cell specifically and mesenchymal tumors, the same set of mechanisms or whether their metastatic dissemination on an set of factors and molecular Indeed, at it that the and of some from mechanisms that have to do with the suggest that the mechanisms of dissemination of a variety of tumor cells will into over the 5 This will the mechanisms underlying the last of the invasion–metastasis As appears to depend on the of cancer cells to tissue to such may happen to occur almost in the primary tumor, a minority of the cells for in one or another even they the primary tumor. however, that most such occur cancer cells the primary tumor, in a distant tissue and through years of until they happen to upon the that their Once they at such such cancer cells can to generate macroscopic metastases, which may in turn serve as for a of metastatic a of metastases that signals the aggressive of progression. however, these are likely to involve in the cancer cells and on of such on the and of the primary tumor and the of the in which they have Hence, while dissemination may be in of a relatively small number of the mechanisms of in various may one be in of of in cell epithelial–mesenchymal transition transcription of
Source: Carcinogenesis
Author: R. A. Weinberg
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2152387535
